Centessa Pharmaceuticals plc (CNTA)
NASDAQ: CNTA · Real-Time Price · USD
17.04
-1.15 (-6.32%)
At close: Nov 22, 2024, 4:00 PM
17.98
+0.94 (5.52%)
After-hours: Nov 22, 2024, 7:27 PM EST
Centessa Pharmaceuticals Market Cap
Centessa Pharmaceuticals has a market cap or net worth of $2.25 billion as of November 22, 2024. Its market cap has increased by 227.17% in one year.
Market Cap
2.25B
Enterprise Value
1.81B
1-Year Change
227.17%
Ranking
Category
Stock Price
$17.04
Market Cap Chart
Since the IPO on May 28, 2021, Centessa Pharmaceuticals's market cap has increased from $1.75B to $2.25B, an increase of 28.49%. That is a compound annual growth rate of 7.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2024 | 2.22B | 185.53% |
| Dec 29, 2023 | 777.13M | 165.01% |
| Dec 30, 2022 | 293.25M | -71.03% |
| Dec 31, 2021 | 1.01B | -42.11% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| LeMaitre Vascular | 2.33B |
| iRhythm Technologies | 2.31B |
| UFP Technologies | 2.29B |
| Alignment Healthcare | 2.29B |
| IDEAYA Biosciences | 2.21B |
| Keros Therapeutics | 2.19B |
| CONMED | 2.18B |
| CG Oncology | 2.18B |